Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 21, 2026.

Comparative review of Francisella tularensis and Francisella novicida

Luke C. Kingry, Jeannine M. Petersen

Frontiers in Cellular and Infection Microbiology · 2014 · Review

doi:10.3389/fcimb.2014.00035

Abstract

Francisella tularensis is the causative agent of the acute disease tularemia. Due to its extreme infectivity and ability to cause disease upon inhalation, F. tularensis has been classified as a biothreat agent. Two subspecies of F. tularensis, tularensis and holarctica, are responsible for tularemia in humans. In comparison, the closely related species F. novicida very rarely causes human illness and cases that do occur are associated with patients who are immune compromised or have other underlying health problems. Virulence between F. tularensis and F. novicida also differs in laboratory animals. Despite this varying capacity to cause disease, the two species share ~97% nucleotide identity, with F. novicida commonly used as a laboratory surrogate for F. tularensis. As the F. novicida U112 strain is exempt from U.S. select agent regulations, research studies can be carried out in non-registered laboratories lacking specialized containment facilities required for work with virulent F. tularensis strains. This review is designed to highlight phenotypic (clinical, ecological, virulence, and pathogenic) and genomic differences between F. tularensis and F. novicida that warrant maintaining F. novicida and F. tularensis as separate species. Standardized nomenclature for F. novicida is critical for accurate interpretation of experimental results, limiting clinical confusion between F. novicida and F. tularensis and ensuring treatment efficacy studies utilize virulent F. tularensis strains.

References 147

  1. 1.

    Abplanalp A. L. Morris I. R. Parida B. K. Teale J. M. Berton M. T. (2009 ). TLR-dependent control of Francisella tularensis infection and host inflammatory responses. PLoS ONE 4:e7920

    Not in our library10.1371/journal.pone.0007920

  2. 2.

    Achtman M. (2008 ). Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu. Rev. Microbiol. 62, 53–70

    Not in our library10.1146/annurev.micro.62.081307.162832

  3. 3.

    Anthony L. S. Gu M. Z. Cowley S. C. Leung W. W. Nano F. E. (1991 ). Transformation and allelic replacement in Francisella spp. J. Gen. Microbiol. 137, 2697–2703

    Not in our library10.1099/00221287-137-12-2697

  4. 4.

    Antwerpen M. H. Schacht E. Kaysser P. Splettstoesser W. D. (2013 ). Complete genome sequence of a Francisella tularensis subsp. holarctica strain from Germany causing lethal infection in common marmosets. Genome Announc. 1:e00135

    Not in our library10.1128/genomea.00135-12

  5. 5.

    Bandara A. B. Champion A. E. Wang X. Berg G. Apicella M. A. McLendon M. (2011 ). Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice. PLoS ONE 6:e19003

    Not in our library10.1371/journal.pone.0019003

  6. 6.
  7. 7.

    Barker J. H. Kaufman J. W. Zhang D. S. Weiss J. P. (2014 ). Metabolic labeling to characterize the overall composition of Francisella Lipid A and LPS grown in broth and in human phagocytes. Innate Immun. 20, 88–103

    Not in our library10.1177/1753425913485308

  8. 8.

    Barker J. R. Chong A. Wehrly T. D. Yu J. J. Rodriguez S. A. Liu J. (2009 ). The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol. Microbiol. 74, 1459–1470

    Not in our library10.1111/j.1365-2958.2009.06947.x

  9. 9.

    Barns S. M. Grow C. C. Okinaka R. T. Keim P. Kuske C. R. (2005 ). Detection of diverse new Francisella-like bacteria in environmental samples. Appl. Environ. Microbiol. 71, 5494–5500

    Not in our library10.1128/aem.71.9.5494-5500.2005

  10. 10.
  11. 11.

    Beckstrom-Sternberg S. M. Auerbach R. K. Godbole S. Pearson J. V. Beckstrom-Sternberg J. S. Deng Z. (2007 ). Complete genomic characterization of a pathogenic A.II strain of Francisella tularensis subspecies tularensis. PLoS ONE 2:e947

    Not in our library10.1371/journal.pone.0000947

  12. 12.

    Bell J. F. Owen C. R. Larson C. L. (1955 ). Virulence of Bacterium tularense. I. A study of the virulence of Bacterium tularense in mice, guinea pigs, and rabbits. J. Infect. Dis. 97, 162–166

    Not in our library10.1093/infdis/97.2.162

  13. 13.

    Ben Nasr A. Klimpel G. R. (2008 ). Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis. J. Leukoc. Biol. 84, 77–85

    Not in our library10.1189/jlb.0807526

  14. 14.

    Berrada Z. L. Telford S. R. 3rd. (2010 ). Diversity of Francisella species in environmental samples from Martha's Vineyard, Massachusetts. Microb. Ecol. 59, 277–283

    Not in our library10.1007/s00248-009-9568-y

  15. 15.

    Birdsell D. N. Stewart T. Vogler A. J. Lawaczeck E. Diggs A. Sylvester T. L. (2009 ). Francisella tularensis subsp. novicida isolated from a human in Arizona. BMC Res. Notes 2:223

    Not in our library10.1186/1756-0500-2-223

  16. 16.

    Brett M. Doppalapudi A. Respicio-Kingry L. B. Myers D. Husband B. Pollard K. (2012 ). Francisella novicida bacteremia after a near-drowning accident. J. Clin. Microbiol. 50, 2826–2829

    Not in our library10.1128/jcm.00995-12

  17. 17.

    Bröms J. E. Meyer L. Sun K. Lavander M. Sjöstedt A. (2012 ). Unique substrates secreted by the type VI secretion system of Francisella tularensis during intramacrophage infection. PLoS ONE 7:e50473

    Not in our library10.1371/journal.pone.0050473

  18. 18.

    Bröms J. E. Sjöstedt A. Lavander M. (2010 ). The role of the Francisella tularensis pathogenicity island in Type VI secretion, intracellular survival, and modulation of host cell signaling. Front. Microbiol. 1:136

    Not in our library10.3389/fmicb.2010.00136

  19. 19.

    Butchar J. P. Cremer T. J. Clay C. D. Gavrilin M. A. Wewers M. D. Marsh C. B. (2008 ). Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS ONE 3:e2924

    Not in our library10.1371/journal.pone.0002924

  20. 20.

    Carniel E. A. I. Cornelis G. Fukushima H. Guinet F. Isberg R. Pham J. (2006 ). Y. enterocolitica and Y. pseudotuberculosis, in The Prokaryotes: A Handbook on the Biology of Bacteria, 3rd Edn., eds Dworkin M. Falkow S. Rosenberg E. Schleifer K.-H. Stackebrandt E. (New York, NY: Springer Verlag), 270–398

    Not in our library

  21. 21.

    Case E. D. Chong A. Wehrly T. D. Hansen B. Child R. Hwang S. (2014 ). The Francisella O-antigen mediates survival in the macrophage cytosol via autophagy avoidance. Cell. Microbiol. [Epub ahead of print].

    Not in our library10.1111/cmi.12246

  22. 22.

    Celebi G. Baruonu F. Ayoglu F. Cinar F. Karadenizli A. Ugur M. B. (2006 ). Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn. J. Infect. Dis. 59, 229–234

    Not in our library

  23. 23.

    Chain P. S. Carniel E. Larimer F. W. Lamerdin J. Stoutland P. O. Regala W. M. (2004 ). Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. U.S.A. 101, 13826–13831

    Not in our library10.1073/pnas.0404012101

  24. 24.

    Champion M. D. Zeng Q. Nix E. B. Nano F. E. Keim P. Kodira C. D. (2009 ). Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog. 5:e1000459

    Not in our library10.1371/journal.ppat.1000459

  25. 25.

    Chaudhuri R. R. Ren C. P. Desmond L. Vincent G. A. Silman N. J. Brehm J. K. (2007 ). Genome sequencing shows that European isolates of Francisella tularensis subspecies tularensis are almost identical to US laboratory strain Schu S4. PLoS ONE 2:e352

    Not in our library10.1371/journal.pone.0000352

  26. 26.

    Child R. Wehrly T. D. Rockx-Brouwer D. Dorward D. W. Celli J. (2010 ). Acid phosphatases do not contribute to the pathogenesis of type A Francisella tularensis. Infect. Immun. 78, 59–67

    Not in our library10.1128/iai.00965-09

  27. 27.

    Chou A. Y. Kennett N. J. Nix E. B. Schmerk C. L. Nano F. E. Elkins K. L. (2013 ). Generation of protection against Francisella novicida in mice depends on the pathogenicity protein PdpA, but not PdpC or PdpD. Microbes Infect. 15, 816–827

    Not in our library10.1016/j.micinf.2013.07.005

  28. 28.

    Clarridge J. E. 3rd. Raich T. J. Sjösted A. Sandström G. Darouiche R. O. Shawar R. M. (1996 ). Characterization of two unusual clinically significant Francisella strains. J. Clin. Microbiol. 34, 1995–2000

    Not in our library10.1128/jcm.34.8.1995-2000.1996

  29. 29.

    Clay C. D. Soni S. Gunn J. S. Schlesinger L. S. (2008 ). Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J. Immunol. 181, 5568–5578

    Not in our library10.4049/jimmunol.181.8.5568

  30. 30.

    Clemens D. L. Lee B. Y. Horwitz M. A. (2005 ). Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect. Immun. 73, 5892–5902

    Not in our library10.1128/iai.73.9.5892-5902.2005

  31. 31.

    Cong Y. Yu J. J. Guentzel M. N. Berton M. T. Seshu J. Klose K. E. (2009 ). Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge. Vaccine 27, 5554–5561

    Not in our library10.1016/j.vaccine.2009.07.034

  32. 32.

    Cowley S. C. Elkins K. L. (2011 ). Immunity to Francisella. Front. Microbiol. 2:26

    Not in our library10.3389/fmicb.2011.00026

  33. 33.

    Cremer T. J. Butchar J. P. Tridandapani S. (2011 ). Francisella subverts innate immune signaling: focus on PI3K/Akt. Front. Microbiol. 5:13

    Not in our library10.3389/fmicb.2011.00013

  34. 34.
  35. 35.

    Dai S. Rajaram M. V. Curry H. M. Leander R. Schlesinger L. S. (2013 ). Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog. 9:e1003114

    Not in our library10.1371/journal.ppat.1003114

  36. 36.

    De Bruin O. M. Duplantis B. N. Ludu J. S. Hare R. F. Nix E. B. Schmerk C. L. (2011 ). The biochemical properties of the Francisella pathogenicity island (FPI)-encoded proteins IglA, IglB, IglC, PdpB and DotU suggest roles in type VI secretion. Microbiology 157, 3483–3491

    Not in our library10.1099/mic.0.052308-0

  37. 37.

    De Carvalho I. L. S. N. Soares T. Ze-Ze L. Nuncio M. S. (2011 ). Francisella-like endosymbiont in Dermacentor reticulatus collected in Portugal. Vector Borne Zoonotic Dis. 11, 185–188

    Not in our library10.1089/vbz.2010.0014

  38. 38.

    Dennis D. T. Inglesby T. V. Henderson D. A. Bartlett J. G. Ascher M. S. Eitzen E. (2001 ). Tularemia as a biological weapon: medical and public health management. J. Am. Med. Assoc. 285, 2763–2773

    Not in our library10.1001/jama.285.21.2763

  39. 39.

    Dotson R. J. Rabadi S. M. Westcott E. L. Bradley S. Catlett S. V. Banik S. (2013 ). Repression of inflammasome by Francisella tularensis during early stages of infection. J. Biol. Chem. 288, 23844–23857

    Not in our library10.1074/jbc.m113.490086

  40. 40.

    Federal Register. (2012 ). Possession, Use, and Transfer of Select Agents and Toxins. 61083–61115 Available online at: https://federalregister.gov/a/2012-24389

    Not in our library

  41. 41.

    Fernandes-Alnemri T. Yu J. W. Juliana C. Solorzano L. Kang S. Wu J. (2010 ). The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11, 385–393

    Not in our library10.1038/ni.1859

  42. 42.

    Francis E. (1925 ). Tularemia. J. Am. Med. Assoc. 84, 1243–1250

    Not in our library

  43. 43.

    Francis E. Felton L. (1953 ). The isolation from the rocky mountain wood tick (Dermacentor andersoni) of strains of Bact. tularense of low virulence for guinea pigs and domestic rabbits. Public Health Rep. 57:44

    Not in our library

  44. 44.

    Gallagher L. A. McKevitt M. Ramage E. R. Manoil C. (2008 ). Genetic dissection of the Francisella novicida restriction barrier. J. Bacteriol. 190, 7830–7837

    Not in our library10.1128/jb.01188-08

  45. 45.

    Garcia Del Blanco N. Gutierrez Martin C. B. De La Puente Redondo V. A. Rodriguez Ferri E. F. (2004 ). In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents. Res. Vet. Sci. 76, 195–198

    Not in our library10.1016/j.rvsc.2003.12.002

  46. 46.

    Georgi E. Schacht E. Scholz H. C. Splettstoesser W. D. (2012 ). Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species. J. Antimicrob. Chemother. 67, 2429–2433

    Not in our library10.1093/jac/dks238

  47. 47.

    Goethert H. K. Telford S. R. 3rd. (2005 ). A new Francisella (Beggiatiales: Francisellaceae) inquiline within Dermacentor variabilis say (Acari: Ixodidae). J. Med. Entomol. 42, 502–505

    Not in our library10.1603/0022-2585(2005)042[0502:anfbfi]2.0.co;2

  48. 48.

    Gray C. G. Cowley S. C. Cheung K. K. Nano F. E. (2002 ). The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol. Lett. 215, 53–56

    Not in our library10.1016/s0378-1097(02)00911-4

  49. 49.

    Gunn J. S. Ernst R. K. (2007 ). The structure and function of Francisella lipopolysaccharide. Ann. N.Y. Acad. Sci. 1105, 202–218

    Not in our library10.1196/annals.1409.006

  50. 50.

    Hall J. D. Woolard M. D. Gunn B. M. Craven R. R. Taft-Benz S. Frelinger J. A. (2008 ). Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect. Immun. 76, 5843–5852

    Not in our library10.1128/iai.01176-08

  51. 51.

    Hollis D. G. Weaver R. E. Steigerwalt A. G. Wenger J. D. Moss C. W. Brenner D. J. (1989 ). Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J. Clin. Microbiol. 27, 1601–1608

    Not in our library10.1128/jcm.27.7.1601-1608.1989

  52. 52.

    Hopla C. E. (1974 ). The ecology of tularemia. Adv. Vet. Sci. Comp. Med. 18, 25–53

    Not in our library

  53. 53.

    Huber B. Escudero R. Busse H. J. Seibold E. Scholz H. C. Anda P. (2010 ). Description of Francisella hispaniensis sp. nov., isolated from human blood, reclassification of Francisella novicida (Larson et al. 1955) Olsufiev et al. 1959 as Francisella tularensis subsp. novicida comb. nov. and emended description of the genus Francisella. Int. J. Syst. Evol. Microbiol. 60, 1887–1896

    Not in our library10.1099/ijs.0.015941-0

  54. 54.

    Ikäheimo I. Syrjälä H. Karhukorpi J. Schildt R. Koskela M. (2000 ). In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J. Antimicrob. Chemother. 46, 287–290

    Not in our library10.1093/jac/46.2.287

  55. 55.

    Ivanov I. N. Mitkova N. Reye A. L. Hubschen J. M. Vatcheva-Dobrevska R. S. Dobreva E. G. (2011 ). Detection of new Francisella-like tick endosymbionts in Hyalomma spp. and Rhipicephalus spp. (Acari: Ixodidae) from Bulgaria. Appl. Environ. Microbiol. 77, 5562–5565

    Not in our library10.1128/aem.02934-10

  56. 56.

    Jellison W. (1974 ). Tularemia in North America. Missoula, MT: University of Montana Foundation

    Not in our library

  57. 57.

    Johansson A. Berglund L. Gothefors L. Sjöstedt A. Tärnvik A. (2000 ). Ciprofloxacin for treatment of tularemia in children. Pediatr. Infect. Dis. J. 19, 449–453

    Not in our library10.1097/00006454-200005000-00011

  58. 58.

    Johansson A. Celli J. Conlan W. Elkins K. L. Forsman M. Keim P. S. (2010 ). Objections to the transfer of Francisella novicida to the subspecies rank of Francisella tularensis. Int. J. Syst. Evol. Microbiol. 60, 1717–1718; author reply 1718–1720.

    Not in our library10.1099/ijs.0.022830-0

  59. 59.

    Johansson A. Urich S. K. Chu M. C. Sjöstedt A. Tärnvik A. (2002 ). In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis. Scand. J. Infect. Dis. 34, 327–330

    Not in our library10.1080/00365540110080773

  60. 60.

    Jones C. L. Napier B. A. Sampson T. R. Llewellyn A. C. Schroeder M. R. Weiss D. S. (2012 ). Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76, 383–404

    Not in our library10.1128/mmbr.05027-11

  61. 61.

    Katz J. Zhang P. Martin M. Vogel S. N. Michalek S. M. (2006 ). Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect. Immun. 74, 2809–2816

    Not in our library10.1128/iai.74.5.2809-2816.2006

  62. 62.

    Kaya A. Uysal I. O. Guven A. S. Engin A. Gulturk A. Icagasioglu F. D. (2011 ). Treatment failure of gentamicin in pediatric patients with oropharyngeal tularemia. Med. Sci. Monit. 17, CR376–CR380

    Not in our library10.12659/msm.881848

  63. 63.

    KEGG. (2014 ). Kyoto Encyclopedia of Genes and Genomes [Online]. (Accessed January 15, 2014). Available online at: http://www.genome.jp/kegg/kegg2.html

    Not in our library

  64. 64.

    Kieffer T. L. Cowley S. Nano F. E. Elkins K. L. (2003 ). Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes Infect. 5, 397–403

    Not in our library10.1016/s1286-4579(03)00052-2

  65. 65.
  66. 66.

    Kim T. H. Sebastian S. Pinkham J. T. Ross R. A. Blalock L. T. Kasper D. L. (2010 ). Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis. J. Biol. Chem. 285, 27839–27849

    Not in our library10.1074/jbc.m110.143859

  67. 67.

    Klimpel G. R. Eaves-Pyles T. Moen S. T. Taormina J. Peterson J. W. Chopra A. K. (2008 ). Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody. Vaccine 26, 6874–6882

    Not in our library10.1016/j.vaccine.2008.09.077

  68. 68.

    Kreizinger Z. Hornok S. Dan A. Hresko S. Makrai L. Magyar T. (2013 ). Prevalence of Francisella tularensis and Francisella-like endosymbionts in the tick population of Hungary and the genetic variability of Francisella-like agents. Vector Borne Zoonotic Dis. 13, 160–163

    Not in our library10.1089/vbz.2012.1065

  69. 69.

    Kugeler K. J. Gurfield N. Creek J. G. Mahoney K. S. Versage J. L. Petersen J. M. (2005 ). Discrimination between Francisella tularensis and Francisella-like endosymbionts when screening ticks by PCR. Appl. Environ. Microbiol. 71, 7594–7597

    Not in our library10.1128/aem.71.11.7594-7597.2005

  70. 70.

    Kugeler K. J. Mead P. S. Janusz A. M. Staples J. E. Kubota K. A. Chalcraft L. G. (2009 ). Molecular epidemiology of Francisella tularensis in the United States. Clin. Infect. Dis. 48, 863–870

    Not in our library10.1086/597261

  71. 71.

    Kuske C. R. Barns S. M. Grow C. C. Merrill L. Dunbar J. (2006 ). Environmental survey for four pathogenic bacteria and closely related species using phylogenetic and functional genes. J. Forensic Sci. 51, 548–558

    Not in our library10.1111/j.1556-4029.2006.00131.x

  72. 72.

    Lapage S. P. (1992 ). International Code of Nomenclature of Bacteria. Washington, DC: ASM Press

    Not in our library

  73. 73.

    Larson C. L. Wicht W. Jellison W. L. (1955 ). A new organism resembling P. tularensis isolated from water. Public Health Rep. 70, 253–258

    Not in our library

  74. 74.

    Larsson P. Elfsmark D. Svensson K. Wikström P. Forsman M. Brettin T. (2009 ). Molecular evolutionary consequences of niche restriction in Francisella tularensis, a facultative intracellular pathogen. PLoS Pathog. 5:e1000472

    Not in our library10.1371/journal.ppat.1000472

  75. 75.

    Larsson P. Oyston P. C. Chain P. Chu M. C. Duffield M. Fuxelius H. H. (2005 ). The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 37, 153–159

    Not in our library10.1038/ng1499

  76. 76.

    Lauriano C. M. Barker J. R. Yoon S. S. Nano F. E. Arulanandam B. P. Hassett D. J. (2004 ). MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc. Natl. Acad. Sci. U.S.A. 101, 4246–4249

    Not in our library10.1073/pnas.0307690101

  77. 77.
  78. 78.

    Lim K. H. Staudt L. M. (2013 ). Toll-like receptor signaling. Cold Spring Harb. Perspect. Biol. 5:a011247

    Not in our library10.1101/cshperspect.a011247

  79. 79.

    Machado-Ferreira E. Piesman J. Zeidner N. S. Soares C. A. (2009 ). Francisella-like endosymbiont DNA and Francisella tularensis virulence-related genes in Brazilian ticks (Acari: Ixodidae). J. Med. Entomol. 46, 369–374

    Not in our library10.1603/033.046.0224

  80. 80.

    Maier T. M. Casey M. S. Becker R. H. Dorsey C. W. Glass E. M. Maltsev N. (2007 ). Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Infect. Immun. 75, 5376–5389

    Not in our library10.1128/iai.00238-07

  81. 81.

    Maier T. M. Havig A. Casey M. Nano F. E. Frank D. W. Zahrt T. C. (2004 ). Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl. Environ. Microbiol. 70, 7511–7519

    Not in our library10.1128/aem.70.12.7511-7519.2004

  82. 82.

    Malik M. Bakshi C. S. Sahay B. Shah A. Lotz S. A. Sellati T. J. (2006 ). Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect. Immun. 74, 3657–3662

    Not in our library10.1128/iai.02030-05

  83. 83.

    Mares C. A. Ojeda S. S. Morris E. G. Li Q. Teale J. M. (2008 ). Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect. Immun. 76, 3001–3010

    Not in our library10.1128/iai.00215-08

  84. 84.

    Mariathasan S. Weiss D. S. Newton K. McBride J. O'rourke K. Roose-Girma M. (2006 ). Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228–232

    Not in our library10.1038/nature04515

  85. 85.

    McCoy G. W. Chapin C. C. (1912 ). Studies of plague, a plague-like disease and tuberculosis among rodents in California. J. Infect. Dis. VI, 170–180

    Not in our library

  86. 86.

    McCrumb F. R. (1961 ). Aerosol infection of man with Pasteurella tularensis. Bacteriol. Rev. 25, 262–267

    Not in our library10.1128/br.25.3.262-267.1961

  87. 87.

    Mdluli K. E. Anthony L. S. Baron G. S. McDonald M. K. Myltseva S. V. Nano F. E. (1994 ). Serum-sensitive mutation of Francisella novicida: association with an ABC transporter gene. Microbiology 140(Pt 12), 3309–3318

    Not in our library10.1099/13500872-140-12-3309

  88. 88.

    Medina E. A. Morris I. R. Berton M. T. (2010 ). Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J. Immunol. 185, 7562–7572

    Not in our library10.4049/jimmunol.0903790

  89. 89.

    Meibom K. L. Charbit A. (2010 ). Francisella tularensis metabolism and its relation to virulence. Front. Microbiol. 1:140

    Not in our library10.3389/fmicb.2010.00140

  90. 90.

    Meric M. Willke A. Finke E. J. Grunow R. Sayan M. Erdogan S. (2008 ). Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS 116, 66–73

    Not in our library10.1111/j.1600-0463.2008.00901.x

  91. 91.

    Meshcheriakova I. S. Kormilitsyna M. I. Rodionova I. V. Konstantinova N. D. (1995 ). [The characteristics of new species of pathogenic microorganisms in the genus Francisella]. Zh. Mikrobiol. Epidemiol. Immunobiol. 5, 3–8

    Not in our library

  92. 92.

    Modise T. Ryder C. Mane S. P. Bandara A. B. Jensen R. V. Inzana T. J. (2012 ). Genomic comparison between a virulent type A1 strain of Francisella tularensis and its attenuated O-antigen mutant. J. Bacteriol. 194, 2775–2776

    Not in our library10.1128/jb.00152-12

  93. 93.

    Molins C. R. Delorey M. J. Yockey B. M. Young J. W. Sheldon S. W. Reese S. M. (2010 ). Virulence differences among Francisella tularensis subsp. tularensis clades in mice. PLoS ONE 5:e10205

    Not in our library10.1371/journal.pone.0010205

  94. 94.

    Moran N. A. (2002 ). Microbial minimalism: genome reduction in bacterial pathogens. Cell 108, 583–586

    Not in our library10.1016/s0092-8674(02)00665-7

  95. 95.

    Mortensen B. L. Fuller J. R. Taft-Benz S. Kijek T. M. Miller C. N. Huang M. T. (2010 ). Effects of the putative transcriptional regulator IclR on Francisella tularensis pathogenesis. Infect. Immun. 78, 5022–5032

    Not in our library10.1128/iai.00544-10

  96. 96.

    Nano F. E. Schmerk C. (2007 ). The Francisella pathogenicity island. Ann. N.Y. Acad. Sci. 1105, 122–137

    Not in our library10.1196/annals.1409.000

  97. 97.

    Nano F. E. Zhang N. Cowley S. C. Klose K. E. Cheung K. K. Roberts M. J. (2004 ). A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186, 6430–6436

    Not in our library10.1128/jb.186.19.6430-6436.2004

  98. 98.

    Nelson M. Lever M. S. Dean R. E. Pearce P. C. Stevens D. J. Simpson A. J. (2010 ). Bioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus). Antimicrob. Agents Chemother. 54, 3922–3926

    Not in our library10.1128/aac.00390-10

  99. 99.

    Okan N. A. Chalabaev S. Kim T. H. Fink A. Ross R. A. Kasper D. L. (2013 ). Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. MBio 4, e00638–e00612

    Not in our library10.1128/mbio.00638-12

  100. 100.

    Okan N. A. Kasper D. L. (2013 ). The atypical lipopolysaccharide of Francisella. Carbohydr. Res. 378, 79–83

    Not in our library10.1016/j.carres.2013.06.015

  101. 101.

    Olsufiev N. G. Emelyanova O. S. Dunayeva T. N. (1959 ). Comparative study of strains of B. tularense in the old and new world and their taxonomy. J. Hyg. Epidemiol. Microbiol. Immunol. 3, 138–149

    Not in our library

  102. 102.

    Ong C. Ooi C. H. Wang D. Chong H. Ng K. C. Rodrigues F. (2004 ). Patterns of large-scale genomic variation in virulent and avirulent Burkholderia species. Genome Res. 14, 2295–2307

    Not in our library10.1101/gr.1608904

  103. 103.

    Owen C. R. Buker E. O. Jellison W. L. Lackman D. B. Bell J. F. (1964 ). Comparative studies of Francisella tularensis and Francisella novicida. J. Bacteriol. 87, 676–683

    Not in our library10.1128/jb.87.3.676-683.1964

  104. 104.

    Pammit M. A. Budhavarapu V. N. Raulie E. K. Klose K. E. Teale J. M. Arulanandam B. P. (2004 ). Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection. Antimicrob. Agents Chemother. 48, 4513–4519

    Not in our library10.1128/aac.48.12.4513-4519.2004

  105. 105.

    Pechous R. D. McCarthy T. R. Mohapatra N. P. Soni S. Penoske R. M. Salzman N. H. (2008 ). A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS ONE 3:e2487

    Not in our library10.1371/journal.pone.0002487

  106. 106.

    Petersen J. M. Carlson J. Yockey B. Pillai S. Kuske C. Garbalena G. (2009a ). Direct isolation of Francisella spp. from environmental samples. Lett. Appl. Microbiol. 48, 663–667

    Not in our library10.1111/j.1472-765x.2009.02589.x

  107. 107.

    Petersen J. M. Mead P. S. Schriefer M. E. (2009b ). Francisella tularensis: an arthropod-borne pathogen. Vet. Res. 40, 7

    Not in our library10.1051/vetres:2008045

  108. 108.

    Petersen J. M. Molins C. R. (2010 ). Subpopulations of Francisella tularensis ssp. tularensis and holarctica: identification and associated epidemiology. Future Microbiol. 5, 649–661

    Not in our library10.2217/fmb.10.17

  109. 109.

    Qin A. Scott D. W. Mann B. J. (2008 ). Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence. Infect. Immun. 76, 3086–3092

    Not in our library10.1128/iai.00363-08

  110. 110.
  111. 111.

    Respicio-Kingry L. B. Yockey M. Yendell B. Ratard S. Hand R. Balsamo J. (2012 ). Laboratory analysis of a Francisella novicida outbreak among prisoners at a Louisiana correctional facility, 2011, in 7th International Conference on Tularemia (Breckenridge, CO).

    Not in our library

  112. 112.

    Richard K. Mann B. J. Stocker L. Barry E. M. Qin A. Cole L. E. (2014 ). Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain. Clin. Vaccine Immunol. 21, 212–226

    Not in our library10.1128/cvi.00738-13

  113. 113.
  114. 114.

    Sampson T. R. Saroj S. D. Llewellyn A. C. Tzeng Y. L. Weiss D. S. (2013 ). A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497, 254–257

    Not in our library10.1038/nature12048

  115. 115.

    Sampson T. R. Weiss D. S. (2013a ). Alternative roles for CRISPR/Cas systems in bacterial pathogenesis. PLoS Pathog. 9:e1003621

    Not in our library10.1371/journal.ppat.1003621

  116. 116.

    Sampson T. R. Weiss D. S. (2013b ). Degeneration of a CRISPR/Cas system and its regulatory target during the evolution of a pathogen. RNA Biol. 10, 1618–1622

    Not in our library10.4161/rna.26423

  117. 117.

    Schmerk C. L. Duplantis B. N. Howard P. L. Nano F. E. (2009 ). A Francisella novicida pdpA mutant exhibits limited intracellular replication and remains associated with the lysosomal marker LAMP-1. Microbiology 155, 1498–1504

    Not in our library10.1099/mic.0.025445-0

  118. 118.

    Schunder E. Rydzewski K. Grunow R. Heuner K. (2013 ). First indication for a functional CRISPR/Cas system in Francisella tularensis. Int. J. Med. Microbiol. 303, 51–60

    Not in our library10.1016/j.ijmm.2012.11.004

  119. 119.

    Scoles G. A. (2004 ). Phylogenetic analysis of the Francisella-like endosymbionts of Dermacentor ticks. J. Med. Entomol. 41, 277–286

    Not in our library10.1603/0022-2585-41.3.277

  120. 120.

    Sharma J. Li Q. Mishra B. B. Pena C. Teale J. M. (2009 ). Lethal pulmonary infection with Francisella novicida is associated with severe sepsis. J. Leukoc. Biol. 86, 491–504

    Not in our library10.1189/jlb.1208728

  121. 121.

    Sjödin A. Svensson K. Ohrman C. Ahlinder J. Lindgren P. Duodu S. (2012 ). Genome characterisation of the genus Francisella reveals insight into similar evolutionary paths in pathogens of mammals and fish. BMC Genomics 13:268

    Not in our library10.1186/1471-2164-13-268

  122. 122.

    Skerman V. B. D. McGowan V. Sneath P. H. A. (eds.). (1980 ). Approved lists of bacterial names. Int. J. Syst. Bacteriol. 30, 225–420

    Not in our library

  123. 123.

    Stackebrandt E. Frederiksen W. Garrity G. M. Grimont P. A. Kampfer P. Maiden M. C. (2002 ). Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology. Int. J. Syst. Evol. Microbiol. 52, 1043–1047

    Not in our library10.1099/ijs.0.02360-0

  124. 124.

    Steward J. Piercy T. Lever M. S. Simpson A. J. Brooks T. J. (2006 ). Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin. Int. J. Antimicrob. Agents 27, 439–443

    Not in our library10.1016/j.ijantimicag.2006.02.006

  125. 125.

    Sutera V. Levert M. Burmeister W. P. Schneider D. Maurin M. (2014 ). Evolution toward high-level fluoroquinolone resistance in Francisella species. J. Antimicrob. Chemother. 69, 101–110

    Not in our library10.1093/jac/dkt321

  126. 126.

    Svensson K. Sjödin A. Bystrom M. Granberg M. Brittnacher M. J. Rohmer L. (2012 ). Genome sequence of Francisella tularensis subspecies holarctica strain FSC200, isolated from a child with tularemia. J. Bacteriol. 194, 6965–6966

    Not in our library10.1128/jb.01040-12

  127. 127.

    Tärnvik A. Berglund L. (2003 ). Tularaemia. Eur. Respir. J. 21, 361–373

    Not in our library10.1183/09031936.03.00088903

  128. 128.

    Telepnev M. Golovliov I. Grundström T. Tärnvik A. Sjöstedt A. (2003 ). Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell. Microbiol. 5, 41–51

    Not in our library10.1046/j.1462-5822.2003.00251.x

  129. 129.

    Tempel R. Lai X. H. Crosa L. Kozlowicz B. Heffron F. (2006 ). Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect. Immun. 74, 5095–5105

    Not in our library10.1128/iai.00598-06

  130. 130.

    Thomas R. M. Titball R. W. Oyston P. C. Griffin K. Waters E. Hitchen P. G. (2007 ). The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect. Immun. 75, 371–378

    Not in our library10.1128/iai.01241-06

  131. 131.

    Thomas R. M. Twine S. M. Fulton K. M. Tessier L. Kilmury S. L. Ding W. (2011 ). Glycosylation of DsbA in Francisella tularensis subsp. tularensis. J. Bacteriol. 193, 5498–5509

    Not in our library10.1128/jb.00438-11

  132. 132.

    Tindall B. J. Kampfer P. Euzeby J. P. Oren A. (2006 ). Valid publication of names of prokaryotes according to the rules of nomenclature: past history and current practice. Int. J. Syst. Evol. Microbiol. 56, 2715–2720

    Not in our library10.1099/ijs.0.64780-0

  133. 133.

    Tomaso H. Al Dahouk S. Hofer E. Splettstoesser W. D. Treu T. M. Dierich M. P. (2005 ). Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains. Int. J. Antimicrob. Agents 26, 279–284

    Not in our library10.1016/j.ijantimicag.2005.07.003

  134. 134.

    Urich S. K. Petersen J. M. (2008 ). In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob. Agents Chemother. 52, 2276–2278

    Not in our library10.1128/aac.01584-07

  135. 135.

    Valade E. Vaissaire J. Merens A. Hernandez E. Gros C. Le Doujet C. (2008 ). Susceptibility of 71 French isolates of Francisella tularensis subsp. holarctica to eight antibiotics and accuracy of the Etest method. J. Antimicrob. Chemother. 62, 208–210

    Not in our library10.1093/jac/dkn146

  136. 136.

    Vinogradov E. Conlan W. J. Gunn J. S. Perry M. B. (2004 ). Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112). Carbohydr. Res. 339, 649–654

    Not in our library10.1016/j.carres.2003.12.013

  137. 137.

    Vinogradov E. Perry M. B. (2004 ). Characterisation of the core part of the lipopolysaccharide O-antigen of Francisella novicida (U112). Carbohydr. Res. 339, 1643–1648

    Not in our library10.1016/j.carres.2004.04.013

  138. 138.

    Vinogradov E. Perry M. B. Conlan J. W. (2002 ). Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 269, 6112–6118

    Not in our library10.1046/j.1432-1033.2002.03321.x

  139. 139.

    Weber I. B. Turabelidze G. Patrick S. Griffith K. S. Kugeler K. J. Mead P. S. (2012 ). Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases. Clin. Infect. Dis. 55, 1283–1290

    Not in our library10.1093/cid/cis706

  140. 140.

    Weiss D. S. Brotcke A. Henry T. Margolis J. J. Chan K. Monack D. M. (2007a ). In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl. Acad. Sci. U.S.A. 104, 6037–6042

    Not in our library10.1073/pnas.0609675104

  141. 141.

    Weiss D. S. Henry T. Monack D. M. (2007b ). Francisella tularensis: activation of the inflammasome. Ann. N.Y. Acad. Sci. 1105, 219–237

    Not in our library10.1196/annals.1409.005

  142. 142.

    Whipp M. J. Davis J. M. Lum G. De Boer J. Zhou Y. Bearden S. W. (2003 ). Characterization of a novicida-like subspecies of Francisella tularensis isolated in Australia. J. Med. Microbiol. 52, 839–842

    Not in our library10.1099/jmm.0.05245-0

  143. 143.

    Whitehouse C. A. Kesterson K. E. Duncan D. D. Eshoo M. W. Wolcott M. (2012 ). Identification and characterization of Francisella species from natural warm springs in Utah, USA. Lett. Appl. Microbiol. 54, 313–324

    Not in our library10.1111/j.1472-765x.2012.03214.x

  144. 144.

    WHO. (2007 ). WHO Guidelines on Tularaemia. Geneva: World Health Organization

    Not in our library

  145. 145.

    Zarrella T. M. Singh A. Bitsaktsis C. Rahman T. Sahay B. Feustel P. J. (2011 ). Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS ONE 6:e22335

    Not in our library10.1371/journal.pone.0022335

  146. 146.

    Zimmer A. L. Thoden J. B. Holden H. M. (2013 ). Three-dimensional structure of a sugar N-formyltransferase from Francisella tularensis. Protein Sci. [Epub ahead of print].

    Not in our library10.1002/pro.2409

  147. 147.

    Zogaj X. Wyatt G. C. Klose K. E. (2012 ). Cyclic di-GMP stimulates biofilm formation and inhibits virulence of Francisella novicida. Infect. Immun. 80, 4239–4247

    Not in our library10.1128/iai.00702-12

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.